ARCHIVES

Conversation With The Cancer Letter: How ASCO’s Guideline Differs—And Why

This article is from The Cancer Letter archive.

Vol. 38 No. 29 | July 20, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Division Directors Seek Litton Phaseout, NIH Takeover At Frederick

October 27, 1978

Linda Weiss, director of NCI Office of Cancer Centers, to Retire in March 2015

November 26, 2014

ACS Awards Medals to Holland, Sporn, RWJ Foundation

December 2, 1994

In Brief: Van Andel Institute to Build Epigenetics Hub

February 28, 2014

NCI Programs: Researchers Take “Director’s Challenge” to Develop Molecular Profiles of Tumors

December 10, 1999

FDA Advisors Discuses Establishment of Standards for Showing Equivalence

December 17, 1999